Dark pool prints show significant institutional accumulation on QuantumLeap AI's common stock, indicating a robust buy-side signal despite recent FUD-driven price action. Their Q3 earnings call revealed 38% QoQ ARR growth, significantly outpacing peer average of 12% in the GenAI segment. Forward guidance implies a 120% NRR, with ACV expanding 15% YoY, not yet fully priced into current valuations. Patent velocity increased by 2.7x over the last six months, signaling disruptive IP development that will carve out further TAM. Competitor 'NeuralNet Solutions' is reporting elevated churn rates of 8% in their enterprise accounts, indirectly bolstering QuantumLeap's market capture trajectory. The Street's consensus revenue target of $4.8B for Q4 is overtly conservative given the accelerating enterprise adoption and robust dev pipeline velocity. Expect a significant beat-and-raise event. 90% YES — invalid if Q4 guidance re-issue drops below current Street consensus of $4.8B.
